TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2025
Back to search
Official data from USPTO
GI CANCER CHRONICLES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GI CANCER CHRONICLES
ST13
US500000098449528Class
44
Filing
98449528
Registration
7628469
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/16/2025
Trademark type
Word
Nice classes
44
Filing date
03/14/2024
Registration date
12/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
03/04/2024
First use in commerce
03/04/2024
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
GLUECK, CHRISTOPHER
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Astellas Pharma Inc.
Representatives
Christopher Bolinger Astellas Pharma Inc.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical information
Publications
History of USPTO decisions and trademark events.
15 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2025
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/24/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2024
GNRT
NON-FINAL ACTION E-MAILED
09/03/2024
CNRT
NON-FINAL ACTION WRITTEN
09/03/2024
DOCK
ASSIGNED TO EXAMINER
08/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2024
NWAP
NEW APPLICATION ENTERED
03/14/2024
Continuous trademark protection
Get notified about every new filing that threatens GI CANCER CHRONICLES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.